期刊文献+

大肠癌中Fas、FasL、FAP-1的表达及意义 被引量:3

Expression of Fas, FasL and FAP-1 in colorectal carcinoma and its significance
暂未订购
导出
摘要 目的:研究大肠癌组织中Fas、FasL及FAP-1的表达状况及临床意义。方法:用Fas、FasL多克隆抗体及FAP-1单克隆抗体对42例大肠癌组织标本进行免疫组化染色,检测其Fas、FasL及FAP-1的蛋白表达,并以相应的切缘正常大肠组织作对照。结果:大肠癌组织中Fas表达(36%)显著低于正常大肠黏膜上皮(60%)(P<0.05),且粘液腺癌及印戒细胞癌Fas表达率显著低于管状、乳头状腺癌(P<0.05),另外,正常大肠粘膜固有层的淋巴细胞及浸润肿瘤的淋巴细胞可见Fas表达;正常的大肠粘膜上皮表达FasL(40%),恶变后的大肠粘膜FasL表达上调(71%),两者表达率有显著性差异(P<0.05),且溃疡型及浸润型大肠癌较隆起型表达率高(P<0.05),浸润至正常大肠粘膜及肿瘤的淋巴细胞未见或偶见FasL表达;大肠癌细胞无论其Fas表达高低都未见FAP-1表达。结论:大肠癌细胞通过Fas表达下调和(或)FasL表达上调以实现其免疫逃避,Fas、FasL的表达状况与肿瘤病理类型有关,粘液腺癌及印戒细胞癌、溃疡型及浸润型大肠癌的恶性程度高、预后差可能与其Fas、FasL的表达异常有关;FAP-1在大肠癌免疫逃避中可能不起重要作用。 Purpose: To investigate the expression of Fas, FasL and FAP-1 protein in colorectal carcinoma and its clinical significance. Methods: The expression of Fas, FasL and FAP-1 was examined in 42 cases of colorectal cancer with Fas, FasL and FAP-1 clonal antibody by immunohistochemistry, and then compared with 42 cases of normal colorectal tissue of incisal edge. Results: Fas expression rate was lower in colorectal cancer(36%) than that in normal mucosa(60%) (P < 0. 05), and the expression of Fas in papillary and tubular adenocarcinoma was stronger than that in mucous adenocarcinoma and signet-ring cell carcinoma. Besides, expression of Fas was found in lymphocytes infiltrated in normal mucosa and tumor; FasL expression was found in 17 out of 42 cases of normal colorectal mucosa (40%), and 30 out of 42 cases of colorectal cancer (71%), respectively(P <0. 05), and the dyeing intensity was stronger in cancer tissue, the expression of FasL in ulcerative and infiltrating cancer is higher than that in exophytic cancer, but, expression of FasL was not found in lymphocytes infiltrated in normal colorectal mucosa and tumor; the expression of FAP-1 protein was not found in colorectal carcinoma, however, FAP-1 was expressed in fibroblast in stroma of carcinoma. Conclusions: Colorectal cancer escapes immune survillance by downregulation of Fas expression and( or) upregulation of FasL expression. The status of Fas/FasL expression is related to the pathological type, it may play an important role in the poor prognosis and high malignancy of mucous adenocarcinoma, signet-ring cell carcinoma and ulcerative, infiltrating colorectal carcinoma. FAP-1 may have no relation with the immune escape of colorectal carcinoma.
出处 《中国癌症杂志》 CAS CSCD 2004年第2期119-122,共4页 China Oncology
关键词 大肠癌 FAS/FASL FAP-1 蛋白表达 免疫逃避 colorectal cancer Fas/FasL FAP-1 protein expression immune escape
  • 相关文献

参考文献9

  • 1French LE, Hahne M, Viard 1, et al. Fas and Fas Ligand in embryos and adult mice: ligand expression in several immuneprivilledged tissues and coexpression in adult tissues characterized by apoptotic cell turnover[J]. J Cell Biol,1996,133(2):335-343.
  • 2Moiler P, Koretz K, Leihauser F, et al. Expression of APO-1(CD95),a member of the NGF/ TNF receptor superfamily, in nomal and neoplastic colon epithelium[J]. lnt J Cancer, 1994,57(3):371-377.
  • 3Shiraki K, Tsuji N, Shioda T, et al. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas [J]. Med Sci,1997,94(12):6420-66425.
  • 4Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in immune privilege[J]. Immunol Today, 1997,18(5):240-244.
  • 5Sato T, Irie S, Kitada S, et al. FAP-1: a protein tyrosine phosphatase that associates with Fas[J]. Science, 1995,268(5209):411-415.
  • 6Weller M, Malipiero U, Rensing-Ehl A, et al. Fas/APO-1 gene transfer for human malignant glioma[J]. Cancer Res, 1995,55(13):2936-2944.
  • 7Lee SH, Shin MS, Lee JY, et al. In vivo expression of soluble Fas and FAP-1: possible mechanism of Fas resistance in human hepatoplastomas[J]. J Pathol,1999 ,188(2):207-212.
  • 8Houghton JA, Harwood FG, Gibson AA, et al. The Fas signaling pathway is functional in colon carcinoma cells and induces apoptosis [J]. Clin Cancer Res, 1997,3 (12: Pt 1):2205-2209.
  • 9O′connell J, 0 ′Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand [J]. J Exp Meal, 1996,184(3): 1075-1082.

同被引文献20

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部